Specifically, JNK1/2 prevents spontaneous breast tumor development in mice heterozygous for P53 and inhibits tumor development in transgenic mice expressing the polyoma middle T oncogene in the mammary gland39,40. Here, TP53 is linked to breast neoplasm.